• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions'...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 10, 2020 at 10:52: AM
via Moderna is on a steady march to market with its mRNA-based COVID-19 vaccine, and the company is snapping up manufacturing capacity along the way. After inking one fill-finish deal with major CDMO Catalent last month, Moderna has now put its name to a second pact.

article source
 




Top Bottom
Back
Quote